Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
W. Tanaka, H. Tamiya, K. Matsuta, S. Noguchi, M. Horie, H. Yoshihara, M. Kawakami, M. Suzuki, Y. Sakamoto (Tokyo, Japan). Evaluation of galactomannan (GM) antigen in patients with rheumatoid arthritis (RA). Eur Respir J 2010; 36: Suppl. 54, 4952

Member's Comments

No comment yet.

Related content which might interest you: Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA) Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA) Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 The lung in rheumatoid arthritis: drugs versus underlying disease Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective Year: 2009 Pulmonary involvement in patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 381s Year: 2006 Evaluation of the sub-maximal aerobic capacity of patients with rheumatoid arthritis (RA): preliminary data Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Analysis of lung diseases associated with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 307s Year: 2006 The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA) Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 The correlation between lung function parameters, and level of activity in seropositive rheumatoid arthritis Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Pulmonary manifestations in patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006 Rituximab improves interstitial lung disease in rheumatoid arthritis patients Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 QuantiFERON-TB GOLD vs. TST methods of detection tuberculosis infection in rheumatoid arthritis patients with previously TNF α inhibitors treatment Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Pulmonary involvement in rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Pulmonary involvement in rheumatoid arthritis Source: Eur Respir Monogr 2019; 86: 44-67 Year: 2019 Interstitial lung disease in patients with rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients Source: Eur Respir J 2014; 44: 1082-1085 Year: 2014 Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 Involving lung in rheumatoid arthritis Source: Eur Respir J 2002; 20: Suppl. 38, 60s Year: 2002 The pleura and rheumatoid arthritis: A case series Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery Year: 2012